Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adrenocortical Carcinoma × lenvatinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 52 Cholangiocarcinoma 18 Carcinoma, Renal Cell 13 Biliary Tract Neoplasms 10 Stomach Neoplasms 8 Thyroid Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Neoplasms 6 Endometrial Neoplasms 6 Uterine Cervical Neoplasms 5 Recurrence 4 Ovarian Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Thyroid Carcinoma, Anaplastic 3 Thyroid Cancer, Papillary 3 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Cirrhosis, Familial, with Pulmonary Hypertension 3 Advanced Biliary Tract Cancer 3 Adenocarcinoma, Follicular 3 Vulvar Neoplasms 2 Uveal Melanoma 2 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Pancreatic Neoplasms 2 Mesothelioma, Malignant 2

Interventions

pembrolizumab 5 Mitotane 5 Cisplatin 4 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 sodium thiosulfate 2 relacorilant 2 cixutumumab 2 cemiplimab 2 camrelizumab 2 cabozantinib 2 apatinib 2 Nivolumab 2 Ipilimumab 2 Etoposide 2 Doxorubicin 2 Cytoreduction Surgical Procedures 2 lenvatinib 1 gossypol acetic acid 1 dostarlimab 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vincristine 1 Suramin 1 Sorafenib 1 Ritonavir 1 Radiotherapy 1 Paclitaxel 1 Oxaliplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05036434 2026-01-23

ACCOMPLISH

National Cancer Center, Korea

Phase 2 Active not recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡